Agree, CR wouldn't be a bad thing. If you look at another Pharma IBX , they raised all the way and still the SP has managed to go higher and are now sitting on MC around 170m from a low of 30-40 m only a few months ago...
Hence parter or CR will only do good to the SP even though I m more confident that a partner is coming soon. DMD, Inflammation market and ANP results are too good to be ignored by any Pharma ..
IMO
Agree, CR wouldn't be a bad thing. If you look at another Pharma...
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.9¢ |
Change
-0.001(1.25%) |
Mkt cap ! $83.73M | |||
| Open | High | Low | Value | Volume |
| 8.1¢ | 8.2¢ | 7.9¢ | $153.8K | 1.914M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 927041 | 7.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.1¢ | 218878 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| PER (ASX) Chart |